Moreover, our present study also suggests that the interesting data about Smad1 gene knockdown in human LN18 glioblastoma cells leading to the cell death might be an important pharmaceutic target finding for glioblastoma cell survival. The gene discussed is SMAD1; the disease is glioblastoma.